Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

Contact
Request a demo
Request data updates
Add a company

Research

Companies
Investors
People

aVenture

Sitemap
Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage

Loading

Loading

Alexis Borisy

AddedMar 31, 2024

UpdatedMay 31, 2026

Alexis Borisy

Alexis Borisy

Board Member, National Venture Capital Association

Crunchbase LinkedIn

Alexis Borisy's Career

National Venture Capital Association

National Venture Capital Association

Washington, D.C., DC, US

Board Member· Board

Foundation Medicine

Foundation Medicine

Cambridge, MA, US

Board Member· Board

Curie.Bio

Boston, MA, US

Board Member· Board

Tango Therapeutics

Tango Therapeutics

Boston, MA, US

Board Member· Board

Relay Therapeutics

Relay Therapeutics

Cambridge, MA, US

Board Member· Board

Revolution Medicines

Revolution Medicines

Redwood City, CA, US

Board Member· Board

Blueprint Medicines

Blueprint Medicines

Cambridge, MA, US

Co-Founder

Celsius Therapeutics

Celsius Therapeutics

Cambridge, MA, US

Board Member· Board

Idrx

Plymouth, MA, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview

aVenture product preview

aVenture product preview

Alexis Borisy's Career

National Venture Capital Association

National Venture Capital Association

NonprofitNonprofit721982Washington, D.C., DC, US

Board Member· Board

Recent news

a16z spends $1.49M in Washington lobbying, while rivals mostly sit outTechCrunch · 2025

Leadership at National Venture Capital Association

Jan GarfinkleBoard Member

Nick WashburnBoard Member

Vic ParkerBoard Member

Rob KettersonBoard Member

Jennifer TeganBoard Member

Niten MalhanBoard Member

Similar to National Venture Capital Association

Venture for AmericaNew York City, NY, USest. 2011Venture for AmericaNew York City, NY, US · est. 2011

Venture for America: A non-profit fostering economic growth in US cities through entrepreneurship training.

VentureWellHadley, MA, USTrainingest. 1995VentureWellHadley, MA, US · est. 1995

VentureWell: Funding, training, and catalyzing student-led ventures for social and environmental impact.

Activation CapitalRichmond, VA, USInnovation Programsest. 1993Activation CapitalRichmond, VA, US · est. 1993

Empowering innovation and talent in Richmond's ecosystem.

Nonprofit · $15M3

Western New York Venture AssociationBuffalo, NY, USBusiness, Investmentest. 1989Western New York Venture AssociationBuffalo, NY, US · est. 1989

WNY Venture Association: Promoting business and investment opportunities in Western New York.

Foundation Medicine

Foundation Medicine

Public$96.5M6622010Cambridge, MA, US

Board Member· Board

Leadership at Foundation Medicine

Krishna YeshwantBoard Member

Daniel O'DayBoard Member

Michael PelliniBoard Member

Evan JonesBoard Member

Brian AlexanderCEO

Curie.Bio

Series B262022Boston, MA, US

Board Member· Board

Leadership at Curie.Bio

Zach WeinbergCo-Founder & CEO

Christoph LengauerCo-Founder

Similar to Curie.Bio

Bioventure PartnersChapel Hill, NC, USAdvisory, InvestmentBioventure PartnersChapel Hill, NC, US

Bioventure Partners: Investing in and advising high-impact, tech-driven life science startups.

BiotechonomyNewton, MA, USBiotechonomyNewton, MA, US

Biotechonomy: A venture capital firm specializing in equity financing and management aid for innovative life science startups.

Curi BioSeattle, WA, USBiotech, Drug Discoveryest. 2015Curi BioSeattle, WA, US · est. 2015

Curi Bio: Accelerating next-gen medicine discovery through human cells, systems, and data integration.

Series A · $20.4M45

Orchid BioVenturesRockville, MD, USBiotechest. 2020Orchid BioVenturesRockville, MD, US · est. 2020

Orchid BioVentures: A venture studio advancing novel biotech solutions for unmet patient needs.

Pre-Seed · $480k30

Tango Therapeutics

Tango Therapeutics

Public$351M1102017Boston, MA, US

Board Member· Board

Leadership at Tango Therapeutics

José BaselgaCo-Founder

Timothy LuCo-Founder

Cary PfefferBoard Member

William G. KaelinBoard Member

Antoni RibasBoard Member

Lesley Ann CalhounBoard Member

Similar to Tango Therapeutics

Marengo TherapeuticsCambridge, MA, USCancer Treatmentest. 2015Marengo TherapeuticsCambridge, MA, US · est. 2015

Marengo Therapeutics: A clinical-stage biotech company dedicated to improving patient lives.

Series B · $80M36

GO TherapeuticsCambridge, MA, USCancer Therapiesest. 2014GO TherapeuticsCambridge, MA, US · est. 2014

GO Therapeutics, Inc.: A US-based biotech firm specializing in cancer-specific immunotherapies and drugs.

Series A · $5M11

TG TherapeuticsNew York City, NY, USCancer Treatments, Pharmaceuticalsest. 1993TG TherapeuticsNew York City, NY, US · est. 1993

TG Therapeutics: A biopharmaceutical firm innovating cancer treatments, focusing on non-Hodgkins lymphoma.

Public · $205M226

Window TherapeuticsBoston, MA, USCancer Treatmentest. 2021Window TherapeuticsBoston, MA, US · est. 2021

Window Therapeutics: A biotech firm innovating targeted cancer treatments for unmet patient needs.

Angel · $256k4

Relay Therapeutics

Relay Therapeutics

Public$1.2B3272016Cambridge, MA, US

Board Member· Board

Leadership at Relay Therapeutics

Mark MurckoBoard Member

Laura ShawverBoard Member

Kanishka PothulaBoard Member

Steve KafkaBoard Member

Linda HillBoard Member

Jami RubinBoard Member

Revolution Medicines

Revolution Medicines

Public$1.1B2462014Redwood City, CA, US

Board Member· Board

Recent news

Reed Jobs would rather talk about curing cancer than his last nameTechCrunch · 2026

Leadership at Revolution Medicines

Barbara WeberBoard Member

Liz McKee AndersonBoard Member

Martin BurkeBoard Member

Eric T. SchmidtBoard Member

Mark A. GoldsmithBoard Member

Kevan ShokatBoard Member

Blueprint Medicines

Blueprint Medicines

Public$2.4B6412008Cambridge, MA, US

Co-Founder

Leadership at Blueprint Medicines

George DemetriBoard Member

Daniella BeckmanBoard Member

Mark GoldbergBoard Member

Brian DrukerCo-Founder

Kate HavilandBoard Member

Daniel LynchBoard Member

Celsius Therapeutics

Celsius Therapeutics

Series B$148M722018Cambridge, MA, US

Board Member· Board

Leadership at Celsius Therapeutics

Tariq KassumCEO

Neil ExterBoard Member

Aviv RegevFounder

Similar to Celsius Therapeutics

Cedilla TherapeuticsCambridge, MA, USTherapeuticsest. 2018Cedilla TherapeuticsCambridge, MA, US · est. 2018

Cedilla Therapeutics: A Massachusetts-based biotech firm innovating small molecule disease treatments.

Series B · $138.8M45

CellaritySomerville, MA, USMedicine Developmentest. 2017CellaritySomerville, MA, US · est. 2017

Cellarity, a Flagship Pioneering company, harnesses machine learning for innovative medicine development.

Series C · $294M165

Athos TherapeuticsTorrance, CA, USTherapeuticsest. 2019Athos TherapeuticsTorrance, CA, US · est. 2019

Athos Therapeutics: Pioneering AI-based precision treatments for autoimmune diseases and cancer.

Series A · $19.3M15

Cogent BiosciencesWaltham, MA, USBiotech, Therapiesest. 2014Cogent BiosciencesWaltham, MA, US · est. 2014

US-based Cogent Biosciences develops biotech solutions for genetically driven diseases.

Public · $692.7M138

Idrx

Series A$122M352022Plymouth, MA, US

Co-Founder

Leadership at Idrx

Ben AuspitzCo-Founder

George DemetriCo-Founder

Robert ForresterCo-Founder

Nicholas LydonCo-Founder

Alexis Borisy's Similar Executives & Operators

Lau Eng BoonBoard Member · Bukalapak

Achmad ZakyCo-Founder · Bukalapak

Jay Geoffrey WacherBoard Member · Bukalapak

Nugroho HerucahyonoCo-Founder · Bukalapak

Soemantri BrodjonegoroBoard Member · Bukalapak

Bo ZhangCo-Founder · DiDi

WILL WEI CHENGBoard Member · DiDi

Dhirubhai H. AmbaniBoard Member · Reliance Retail

People Similar to Alexis Borisy

Dan LynchBoard Member · 2seventy bio

Mark KoulogeorgeBoard Member · Part Analytics

David PerryCo-Founder · Nexprise

Eric ChenFounder · Relay2

Michael GreeleyCo-Founder · Flare Capital Partners

Glenn MuirBoard Member · G1 Therapeutics